Provinces pursue OxyContin maker for $67B US in costs associated with Canada’s opioid crisis
In an effort to claw back the public health-care costs incurred by the opioid crisis, Canada’s provinces have filed a $67.4-billion US claim against OxyContin producer Purdue Pharma. OxyContin was introduced as a pain medication about two decades ago, marking what addiction experts recognize as the beginning of the opioid crisis. (Toby Talbot/The Associated Press)In an effort…